Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases
Buparvaquone (BPQ), a veterinary drug, was formulated as nanostructured lipid carriers (NLC) for leishmaniases treatment. The formulation design addressed poor water solubility of BPQ and lack of human drug delivery system. The DSC/TG and microscopy methods were used for solid lipids screening. Soft...
Main Authors: | Lis Marie Monteiro, Raimar Löbenberg, Paulo Cesar Cotrim, Gabriel Lima Barros de Araujo, Nádia Bou-Chacra |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/9781603 |
Similar Items
-
Buparvaquone nanostructured lipid carrier development: physicochemical and in vitro leishmanicidal performances
by: Lis Marie Monteiro
Published: (2017) -
Buparvaquone nanostructured lipid carrier development: physicochemical and in vitro leishmanicidal performances
by: Monteiro, Lis Marie
Published: (2017) -
Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
by: Maheshkumar P Soni, et al.
Published: (2014-01-01) -
Evaluation of the DDSolver Software Applications
by: Jieyu Zuo, et al.
Published: (2014-01-01) -
Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis.
by: Rinez Thapa, et al.
Published: (2021-06-01)